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Abstract
Background
The use of Complementary and Alternative Medicine (CAM) in Australia has been 
steadily increasing. This has resulted in many people infected with Hepatitis C Virus 
(HCV) consulting CAM practitioners in the hope of alleviating some of the debilitating 
symptoms associated with this viral infection. Chronic symptoms often lead to a 
reduction in everyday functional health producing a lower quality of life compared with 
healthy population norms or patients with other forms of liver disease. Current 
recommended pharmaceutical treatment has a sustained virological response in 
approximately 50-60% of patients. Also large numbers of people are either not suitable 
candidates or intolerant to treatment or do not choose this option.
In the mid 1990s, HCV residents in a Sydney alcohol and drug rehabilitation centre who 
were also receiving auricular (ear) acupuncture as part of their rehabilitation program, 
verbally reported decrease in their alanine aminotransferase (ALT) blood levels after 
approximately 16 acupuncture treatments administered over a three month period (Berle 
1997).
Objective
To investigate whether 24 acupuncture treatments over a twelve week period has an 
effect on the health outcomes of people with HCV.
Design
A randomised single blind controlled pilot study with two parallel arms.
Participants
Sixteen applicants who met the eligibility criteria and agreed to participate in the study 
were randomised into either treatment or control group.
Outcome measures
The primary outcome measure was ALT blood levels at the completion of treatment 
(week 12), weeks 16 and 20. The secondary outcomes were HCV PCR quantitative (viral 
load test) and hepatitis quality of life (QoL) questionnaire. In addition a HCV Traditional 
Chinese Medicine (TCM) pattern questionnaire, acupuncture treatment credibility 
questionnaire and acupuncture needling sensation questionnaire were administered.
Setting
Participants were offered treatment at two clinic locations; a private clinic at Guildford 
and at the University of Technology, Sydney (UTS) city campus. Blinded serum 
pathology/testing was conducted through independent Douglass Hanly Moir Pathology 
clinics.
Treatment
Sixteen HCV participants were randomly allocated to two groups; one group receiving 
verum acupuncture treatment and the other receiving invasive sham acupuncture 
treatment. The treatment methodology involved the development of a TCM pattern 
differentiation diagnostic/outcome measure which identified 17 TCM/HCV patterns.
One participant (treatment group) left the study after eight treatments due to work 
commitments.
Results
No significant change was found between the two groups for ALTs, viral load or any 
domains of the QoL measure.
The TCM pattern questionnaire identified the primary, secondary and tertiary TCM 
pattern expressions for HCV within the study group. On completion of the treatment 
phase there was a significant reduction in the secondary and tertiary TCM pattern 
expression for the treatment group (p=0.045 and 0.037 respectively). No significant 
change was found for the control group.
xvi
The acupuncture credibility questionnaire identified that neither the treatment nor control 
group identified the type of treatment they had received; however the treatment group did 
perceive their treatment as more credible than the control group at week 12. There was 
no significant difference found between or within the two groups for the acupuncture 
needling sensation questionnaire.
Conclusions
Despite the small number of participants and no significant changes for ALTs, viral load 
or any domains of the QoL there was a significant difference in the secondary and tertiary 
TCM patterns.
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